Biodexa Pharmaceuticals Plc (BDRX)
0.4314
-0.05
(-11.03%)
USD |
NASDAQ |
Oct 15, 16:00
0.492
+0.06
(+14.05%)
After-Hours: 20:00
Biodexa Pharmaceuticals Cash from Operations (TTM) : -9.219M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.219M |
| December 31, 2025 | -7.385M |
| June 30, 2025 | -13.90M |
| December 31, 2024 | -15.60M |
| June 30, 2024 | -9.669M |
| December 31, 2023 | -8.478M |
| June 30, 2023 | -8.444M |
| December 31, 2022 | -8.264M |
| June 30, 2022 | -8.460M |
| December 31, 2021 | -8.207M |
| June 30, 2021 | -7.567M |
| Date | Value |
|---|---|
| December 31, 2020 | -12.19M |
| June 30, 2020 | -11.24M |
| December 31, 2019 | -8.196M |
| June 30, 2019 | -13.07M |
| December 31, 2018 | -18.17M |
| June 30, 2018 | -15.47M |
| December 31, 2017 | -17.19M |
| June 30, 2017 | -18.09M |
| December 31, 2016 | -16.55M |
| June 30, 2016 | -21.92M |
| December 31, 2015 | -18.84M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| NuCana Plc | -6.332M |
| Mereo BioPharma Group Plc | -25.28M |
| BioNTech SE | 725.62M |
| Silence Therapeutics Plc | -41.79M |
| Autolus Therapeutics Plc | -224.98M |